Sonic Healthcare Ltd logo

Sonic Healthcare Ltd

1
ASX:SHL (Australia)   Ordinary Shares
A$ 26.12 (+0.69%) May 3
24.48
P/B:
1.61
Market Cap:
A$ 12.55B ($ 8.29B)
Enterprise V:
A$ 15.92B ($ 10.51B)
Volume:
960.13K
Avg Vol (2M):
1.45M
Also Trade In:
Volume:
960.13K
Avg Vol (2M):
1.45M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sonic Healthcare Ltd ( ASX:SHL ) from 1990 to May 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sonic Healthcare stock (ASX:SHL) PE ratio as of May 05 2024 is 24.48. More Details

Sonic Healthcare Ltd (ASX:SHL) PE Ratio (TTM) Chart

To

Sonic Healthcare Ltd (ASX:SHL) PE Ratio (TTM) Historical Data

Total 1262
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Sonic Healthcare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-05 24.5 2024-03-01 27.3
2024-05-03 24.5 2024-02-29 28.0
2024-05-02 24.3 2024-02-28 27.5
2024-05-01 24.7 2024-02-27 27.5
2024-04-30 25.1 2024-02-26 27.5
2024-04-29 25.1 2024-02-23 27.5
2024-04-26 24.7 2024-02-22 27.1
2024-04-24 25.1 2024-02-21 27.3
2024-04-23 25.2 2024-02-20 27.4
2024-04-22 24.8 2024-02-19 29.7
2024-04-19 24.6 2024-02-16 29.9
2024-04-18 24.3 2024-02-15 30.0
2024-04-17 24.4 2024-02-14 30.1
2024-04-16 24.8 2024-02-13 30.3
2024-04-15 25.1 2024-02-12 30.1
2024-04-12 25.4 2024-02-09 29.8
2024-04-11 25.8 2024-02-08 29.5
2024-04-10 26.9 2024-02-07 29.3
2024-04-09 27.0 2024-02-06 29.5
2024-04-08 27.3 2024-02-05 29.9
2024-04-05 27.1 2024-02-02 29.8
2024-04-04 27.2 2024-02-01 29.6
2024-04-03 27.2 2024-01-31 30.0
2024-04-02 27.5 2024-01-30 30.1
2024-04-01 27.6 2024-01-29 29.8
2024-03-29 27.6 2024-01-26 29.6
2024-03-28 27.6 2024-01-25 29.6
2024-03-27 27.4 2024-01-24 29.5
2024-03-26 27.4 2024-01-23 29.8
2024-03-25 27.1 2024-01-22 29.5
2024-03-22 26.8 2024-01-19 29.2
2024-03-21 26.4 2024-01-18 28.7
2024-03-20 25.6 2024-01-17 29.4
2024-03-19 25.6 2024-01-16 29.6
2024-03-18 26.1 2024-01-15 30.0
2024-03-15 26.3 2024-01-12 30.0
2024-03-14 26.3 2024-01-11 30.0
2024-03-13 26.6 2024-01-10 29.8
2024-03-12 26.3 2024-01-09 29.9
2024-03-11 26.7 2024-01-08 29.5
2024-03-08 26.7 2024-01-05 29.7
2024-03-07 26.4 2024-01-04 29.5
2024-03-06 26.4 2024-01-03 29.9
2024-03-05 26.3 2024-01-02 30.2
2024-03-04 26.8 2024-01-01 30.1

Sonic Healthcare Ltd (ASX:SHL) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Sonic Healthcare Ltd logo
Sonic Healthcare Ltd
NAICS : 621511 SIC : 8071
ISIN : AU000000SHL7

Share Class Description:

ASX:SHL: Ordinary Shares
Description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand, and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S., and 35% in Europe.